SVS — Svas Biosana SpA Balance Sheet
0.000.00%
- €44.34m
- €89.27m
- €120.31m
- 35
- 94
- 81
- 85
Annual balance sheet for Svas Biosana SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7.22 | 31.1 | 29.5 | 40 | 37.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 33.7 | 35.5 | 43.7 | 49.2 | 50.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 66.8 | 93.1 | 105 | 124 | 125 |
| Net Property, Plant And Equipment | 25.8 | 25.6 | 26.2 | 26.8 | 27.1 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 108 | 136 | 146 | 166 | 166 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 49.1 | 49.6 | 57.2 | 64.7 | 62.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 80.4 | 84.9 | 91.7 | 107 | 103 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 27.7 | 51 | 54.5 | 59 | 62.8 |
| Total Liabilities & Shareholders' Equity | 108 | 136 | 146 | 166 | 166 |
| Total Common Shares Outstanding |